A role of alphaB-crystallin in angiogenesis of diabetic retinopathy
| Project/Area Number |
22890006
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
KASE Satoru 北海道大学, 北海道大学病院, 医員 (60374394)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,068,000 (Direct Cost: ¥2,360,000、Indirect Cost: ¥708,000)
Fiscal Year 2011: ¥1,469,000 (Direct Cost: ¥1,130,000、Indirect Cost: ¥339,000)
Fiscal Year 2010: ¥1,599,000 (Direct Cost: ¥1,230,000、Indirect Cost: ¥369,000)
|
|---|
| Keywords | alpha-crystallin / VEGF / 糖尿病網膜症 / 血管新生 / alphaB-crystallin |
|---|
| Research Abstract |
AlphaB-crystallin, a small heat shock protein, was expressed in CD31-positive microvessels of proliferative membranes in human diabetic retinopathy, whereas alphaB-crystallin was not expressed in normal retinal vessels, alphaB-crystallin expression was colocalized with VEGF immunoreactivity in proliferative membranes of diabetic retinopathy. Researches on alpha-crystallin toward retinal neovascularization leads to discovery of additional treatments with anti-VEGF therapy, whereby the therapeutic target is not direct VEGF protein itself, but a molecule regulating VEGF degradation.
|
Report
(3 results)
Research Products
(14 results)
-
-
-
-
-
[Journal Article] WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing2011
Author(s)
Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, Welsh GI, Cheung MK, Ni L, Kase S, Rennel ES, Symonds KE, Nowak DG, Royer-Pokora B, Saleem MA, Hagiwara M, Schumacher VA, Harper SJ, Hinton DR, Bates DO, Ladomery MR.
-
Journal Title
Cancer Cell
Volume: 20(6)
Issue: 6
Pages: 768-80
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
